chr2-182063785-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001080545.3(PPP1R1C):āc.235A>Gā(p.Ile79Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000211 in 1,612,324 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001080545.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPP1R1C | NM_001080545.3 | c.235A>G | p.Ile79Val | missense_variant | 4/5 | ENST00000682840.1 | NP_001074014.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PPP1R1C | ENST00000682840.1 | c.235A>G | p.Ile79Val | missense_variant | 4/5 | NM_001080545.3 | ENSP00000507052.1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152062Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 248962Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135048
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1460144Hom.: 0 Cov.: 29 AF XY: 0.00000688 AC XY: 5AN XY: 726446
GnomAD4 genome AF: 0.000112 AC: 17AN: 152180Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74406
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 09, 2023 | The c.235A>G (p.I79V) alteration is located in exon 4 (coding exon 4) of the PPP1R1C gene. This alteration results from a A to G substitution at nucleotide position 235, causing the isoleucine (I) at amino acid position 79 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at